Upper airway stimulation (UAS) is a treatment approach for patients with moderate-to-severe obstructive sleep apnea who cannot adhere to continuous positive airway pressure therapy. Our objective was to evaluate added patient benefit and cost-effectiveness of UAS in the German healthcare system.
